nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—Balsalazide—Crohn's disease	0.242	0.325	CbGbCtD
Rosiglitazone—ALB—Crohn's disease	0.208	1	CbGaD
Rosiglitazone—PPARG—Mesalazine—Crohn's disease	0.194	0.26	CbGbCtD
Rosiglitazone—PPARG—Sulfasalazine—Crohn's disease	0.108	0.145	CbGbCtD
Rosiglitazone—PTGS1—Balsalazide—Crohn's disease	0.0611	0.0819	CbGbCtD
Rosiglitazone—PTGS1—Mesalazine—Crohn's disease	0.0488	0.0655	CbGbCtD
Rosiglitazone—SLCO1B1—Sulfasalazine—Crohn's disease	0.0372	0.0499	CbGbCtD
Rosiglitazone—PTGS1—Sulfasalazine—Crohn's disease	0.0273	0.0366	CbGbCtD
Rosiglitazone—ALB—Prednisone—Crohn's disease	0.0163	0.0218	CbGbCtD
Rosiglitazone—CYP2C19—Prednisone—Crohn's disease	0.0106	0.0142	CbGbCtD
Rosiglitazone—PPARG—Methyldopa—Mesalazine—Crohn's disease	0.00195	1	CbGdCrCtD
Rosiglitazone—Mepyramine—SLC22A4—Crohn's disease	0.00188	0.571	CrCbGaD
Rosiglitazone—Haematocrit decreased—Mesalazine—Crohn's disease	0.00175	0.0524	CcSEcCtD
Rosiglitazone—Mepyramine—SLC22A5—Crohn's disease	0.00142	0.429	CrCbGaD
Rosiglitazone—Pleural effusion—Mesalazine—Crohn's disease	0.000852	0.0255	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.00069	0.0207	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000636	0.019	CcSEcCtD
Rosiglitazone—Hypertriglyceridaemia—Prednisone—Crohn's disease	0.000601	0.018	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Azathioprine—Crohn's disease	0.000595	0.0178	CcSEcCtD
Rosiglitazone—Multiple fractures—Prednisone—Crohn's disease	0.000594	0.0178	CcSEcCtD
Rosiglitazone—Fracture—Prednisone—Crohn's disease	0.000594	0.0178	CcSEcCtD
Rosiglitazone—Hepatic failure—Azathioprine—Crohn's disease	0.000578	0.0173	CcSEcCtD
Rosiglitazone—Immune system disorder—Mercaptopurine—Crohn's disease	0.000545	0.0163	CcSEcCtD
Rosiglitazone—Hepatic failure—Mesalazine—Crohn's disease	0.000527	0.0158	CcSEcCtD
Rosiglitazone—Blood triglycerides increased—Prednisone—Crohn's disease	0.000527	0.0158	CcSEcCtD
Rosiglitazone—Malnutrition—Mercaptopurine—Crohn's disease	0.000525	0.0157	CcSEcCtD
Rosiglitazone—Increased appetite—Mesalazine—Crohn's disease	0.000504	0.0151	CcSEcCtD
Rosiglitazone—Anaemia—Mercaptopurine—Crohn's disease	0.000486	0.0145	CcSEcCtD
Rosiglitazone—Leukopenia—Mercaptopurine—Crohn's disease	0.00047	0.0141	CcSEcCtD
Rosiglitazone—Arthralgia—Mercaptopurine—Crohn's disease	0.000447	0.0134	CcSEcCtD
Rosiglitazone—Oedema—Mercaptopurine—Crohn's disease	0.000429	0.0128	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Mesalazine—Crohn's disease	0.000423	0.0127	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00042	0.0126	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000397	0.0119	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000391	0.0117	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00038	0.0114	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000379	0.0113	CcSEcCtD
Rosiglitazone—Weight increased—Mesalazine—Crohn's disease	0.000372	0.0112	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00037	0.0111	CcSEcCtD
Rosiglitazone—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000365	0.0109	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000362	0.0108	CcSEcCtD
Rosiglitazone—ACSL4—mammalian vulva—Crohn's disease	0.000357	0.108	CbGeAlD
Rosiglitazone—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000345	0.0103	CcSEcCtD
Rosiglitazone—Sinusitis—Mesalazine—Crohn's disease	0.000342	0.0103	CcSEcCtD
Rosiglitazone—Erythema multiforme—Azathioprine—Crohn's disease	0.00034	0.0102	CcSEcCtD
Rosiglitazone—ALB—gall bladder—Crohn's disease	0.000336	0.101	CbGeAlD
Rosiglitazone—Fluid retention—Prednisone—Crohn's disease	0.000328	0.00981	CcSEcCtD
Rosiglitazone—Hepatitis—Mesalazine—Crohn's disease	0.000328	0.00981	CcSEcCtD
Rosiglitazone—Immune system disorder—Azathioprine—Crohn's disease	0.000325	0.00973	CcSEcCtD
Rosiglitazone—Oedema peripheral—Mesalazine—Crohn's disease	0.000323	0.00966	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Mesalazine—Crohn's disease	0.000322	0.00964	CcSEcCtD
Rosiglitazone—ACSL4—digestive system—Crohn's disease	0.000313	0.0943	CbGeAlD
Rosiglitazone—Erythema multiforme—Mesalazine—Crohn's disease	0.00031	0.00928	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisone—Crohn's disease	0.000307	0.0092	CcSEcCtD
Rosiglitazone—Eye disorder—Mesalazine—Crohn's disease	0.000306	0.00917	CcSEcCtD
Rosiglitazone—Cardiac disorder—Mesalazine—Crohn's disease	0.000304	0.00911	CcSEcCtD
Rosiglitazone—Immune system disorder—Mesalazine—Crohn's disease	0.000296	0.00886	CcSEcCtD
Rosiglitazone—Diarrhoea—Mercaptopurine—Crohn's disease	0.000293	0.00879	CcSEcCtD
Rosiglitazone—Anaemia—Azathioprine—Crohn's disease	0.000289	0.00867	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisone—Crohn's disease	0.000288	0.00863	CcSEcCtD
Rosiglitazone—Leukopenia—Azathioprine—Crohn's disease	0.00028	0.00839	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Prednisone—Crohn's disease	0.000276	0.00827	CcSEcCtD
Rosiglitazone—Back pain—Mesalazine—Crohn's disease	0.000276	0.00826	CcSEcCtD
Rosiglitazone—Rash—Mercaptopurine—Crohn's disease	0.00027	0.0081	CcSEcCtD
Rosiglitazone—Dermatitis—Mercaptopurine—Crohn's disease	0.00027	0.00809	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisone—Crohn's disease	0.000267	0.00799	CcSEcCtD
Rosiglitazone—Arthralgia—Azathioprine—Crohn's disease	0.000267	0.00798	CcSEcCtD
Rosiglitazone—Myalgia—Azathioprine—Crohn's disease	0.000267	0.00798	CcSEcCtD
Rosiglitazone—Anaemia—Mesalazine—Crohn's disease	0.000264	0.00789	CcSEcCtD
Rosiglitazone—Angioedema—Mesalazine—Crohn's disease	0.000261	0.0078	CcSEcCtD
Rosiglitazone—Cardiac failure—Prednisone—Crohn's disease	0.000257	0.00769	CcSEcCtD
Rosiglitazone—Leukopenia—Mesalazine—Crohn's disease	0.000255	0.00764	CcSEcCtD
Rosiglitazone—Nausea—Mercaptopurine—Crohn's disease	0.000255	0.00763	CcSEcCtD
Rosiglitazone—Infection—Azathioprine—Crohn's disease	0.000254	0.0076	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Azathioprine—Crohn's disease	0.00025	0.00749	CcSEcCtD
Rosiglitazone—Hypertension—Mesalazine—Crohn's disease	0.000246	0.00737	CcSEcCtD
Rosiglitazone—Myalgia—Mesalazine—Crohn's disease	0.000243	0.00727	CcSEcCtD
Rosiglitazone—Arthralgia—Mesalazine—Crohn's disease	0.000243	0.00727	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000233	0.00697	CcSEcCtD
Rosiglitazone—Oedema—Mesalazine—Crohn's disease	0.000233	0.00697	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Mesalazine—Crohn's disease	0.000233	0.00697	CcSEcCtD
Rosiglitazone—Infection—Mesalazine—Crohn's disease	0.000231	0.00692	CcSEcCtD
Rosiglitazone—Nervous system disorder—Mesalazine—Crohn's disease	0.000228	0.00684	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Mesalazine—Crohn's disease	0.000228	0.00682	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000221	0.00661	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000212	0.00635	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000201	0.00602	CcSEcCtD
Rosiglitazone—Fatigue—Mesalazine—Crohn's disease	0.000201	0.00601	CcSEcCtD
Rosiglitazone—Constipation—Mesalazine—Crohn's disease	0.000199	0.00596	CcSEcCtD
Rosiglitazone—Weight increased—Prednisone—Crohn's disease	0.000197	0.0059	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Prednisone—Crohn's disease	0.000195	0.00585	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisone—Crohn's disease	0.00019	0.0057	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisone—Crohn's disease	0.000189	0.00567	CcSEcCtD
Rosiglitazone—PPARG—epithelium—Crohn's disease	0.000185	0.0558	CbGeAlD
Rosiglitazone—Urticaria—Mesalazine—Crohn's disease	0.000185	0.00554	CcSEcCtD
Rosiglitazone—ACSL4—lymph node—Crohn's disease	0.000179	0.0539	CbGeAlD
Rosiglitazone—PPARG—smooth muscle tissue—Crohn's disease	0.000178	0.0538	CbGeAlD
Rosiglitazone—PPARG—skin of body—Crohn's disease	0.000176	0.0531	CbGeAlD
Rosiglitazone—Diarrhoea—Azathioprine—Crohn's disease	0.000175	0.00524	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Prednisone—Crohn's disease	0.00017	0.0051	CcSEcCtD
Rosiglitazone—Dizziness—Azathioprine—Crohn's disease	0.000169	0.00506	CcSEcCtD
Rosiglitazone—Asthenia—Mesalazine—Crohn's disease	0.000167	0.005	CcSEcCtD
Rosiglitazone—Pruritus—Mesalazine—Crohn's disease	0.000165	0.00493	CcSEcCtD
Rosiglitazone—SLCO1B1—digestive system—Crohn's disease	0.000163	0.0492	CbGeAlD
Rosiglitazone—Eye disorder—Prednisone—Crohn's disease	0.000162	0.00485	CcSEcCtD
Rosiglitazone—Rash—Azathioprine—Crohn's disease	0.000161	0.00482	CcSEcCtD
Rosiglitazone—Dermatitis—Azathioprine—Crohn's disease	0.000161	0.00482	CcSEcCtD
Rosiglitazone—PPARG—mammalian vulva—Crohn's disease	0.000161	0.0484	CbGeAlD
Rosiglitazone—Headache—Azathioprine—Crohn's disease	0.00016	0.00479	CcSEcCtD
Rosiglitazone—Diarrhoea—Mesalazine—Crohn's disease	0.000159	0.00477	CcSEcCtD
Rosiglitazone—Immune system disorder—Prednisone—Crohn's disease	0.000157	0.00469	CcSEcCtD
Rosiglitazone—Dizziness—Mesalazine—Crohn's disease	0.000154	0.00461	CcSEcCtD
Rosiglitazone—Nausea—Azathioprine—Crohn's disease	0.000152	0.00455	CcSEcCtD
Rosiglitazone—Malnutrition—Prednisone—Crohn's disease	0.000151	0.00452	CcSEcCtD
Rosiglitazone—Rash—Mesalazine—Crohn's disease	0.000147	0.00439	CcSEcCtD
Rosiglitazone—Dermatitis—Mesalazine—Crohn's disease	0.000147	0.00439	CcSEcCtD
Rosiglitazone—Headache—Mesalazine—Crohn's disease	0.000146	0.00437	CcSEcCtD
Rosiglitazone—PPARG—lymphoid tissue—Crohn's disease	0.000143	0.043	CbGeAlD
Rosiglitazone—PPARG—digestive system—Crohn's disease	0.000141	0.0424	CbGeAlD
Rosiglitazone—Anaemia—Prednisone—Crohn's disease	0.000139	0.00418	CcSEcCtD
Rosiglitazone—Nausea—Mesalazine—Crohn's disease	0.000138	0.00414	CcSEcCtD
Rosiglitazone—Angioedema—Prednisone—Crohn's disease	0.000138	0.00413	CcSEcCtD
Rosiglitazone—Hypertension—Prednisone—Crohn's disease	0.00013	0.0039	CcSEcCtD
Rosiglitazone—Arthralgia—Prednisone—Crohn's disease	0.000128	0.00385	CcSEcCtD
Rosiglitazone—Myalgia—Prednisone—Crohn's disease	0.000128	0.00385	CcSEcCtD
Rosiglitazone—Oedema—Prednisone—Crohn's disease	0.000123	0.00369	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisone—Crohn's disease	0.000123	0.00369	CcSEcCtD
Rosiglitazone—Infection—Prednisone—Crohn's disease	0.000122	0.00366	CcSEcCtD
Rosiglitazone—Nervous system disorder—Prednisone—Crohn's disease	0.000121	0.00362	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000112	0.00336	CcSEcCtD
Rosiglitazone—CYP2C19—digestive system—Crohn's disease	0.000106	0.0321	CbGeAlD
Rosiglitazone—Fatigue—Prednisone—Crohn's disease	0.000106	0.00318	CcSEcCtD
Rosiglitazone—Constipation—Prednisone—Crohn's disease	0.000105	0.00315	CcSEcCtD
Rosiglitazone—PTGS1—epithelium—Crohn's disease	9.89e-05	0.0298	CbGeAlD
Rosiglitazone—Urticaria—Prednisone—Crohn's disease	9.78e-05	0.00293	CcSEcCtD
Rosiglitazone—PTGS1—smooth muscle tissue—Crohn's disease	9.53e-05	0.0287	CbGeAlD
Rosiglitazone—PTGS1—skin of body—Crohn's disease	9.41e-05	0.0284	CbGeAlD
Rosiglitazone—Asthenia—Prednisone—Crohn's disease	8.83e-05	0.00265	CcSEcCtD
Rosiglitazone—Pruritus—Prednisone—Crohn's disease	8.71e-05	0.00261	CcSEcCtD
Rosiglitazone—CYP1A2—digestive system—Crohn's disease	8.68e-05	0.0262	CbGeAlD
Rosiglitazone—PTGS1—mammalian vulva—Crohn's disease	8.58e-05	0.0259	CbGeAlD
Rosiglitazone—Diarrhoea—Prednisone—Crohn's disease	8.42e-05	0.00252	CcSEcCtD
Rosiglitazone—CYP2C9—digestive system—Crohn's disease	8.24e-05	0.0249	CbGeAlD
Rosiglitazone—Dizziness—Prednisone—Crohn's disease	8.14e-05	0.00244	CcSEcCtD
Rosiglitazone—PPARG—lymph node—Crohn's disease	8.04e-05	0.0242	CbGeAlD
Rosiglitazone—Rash—Prednisone—Crohn's disease	7.76e-05	0.00233	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisone—Crohn's disease	7.76e-05	0.00232	CcSEcCtD
Rosiglitazone—Headache—Prednisone—Crohn's disease	7.71e-05	0.00231	CcSEcCtD
Rosiglitazone—ALB—lymph node—Crohn's disease	7.54e-05	0.0227	CbGeAlD
Rosiglitazone—PTGS1—digestive system—Crohn's disease	7.53e-05	0.0227	CbGeAlD
Rosiglitazone—Nausea—Prednisone—Crohn's disease	7.31e-05	0.00219	CcSEcCtD
Rosiglitazone—CYP2D6—digestive system—Crohn's disease	6.19e-05	0.0186	CbGeAlD
Rosiglitazone—PTGS1—lymph node—Crohn's disease	4.3e-05	0.013	CbGeAlD
Rosiglitazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Crohn's disease	4.26e-05	0.0104	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	4.09e-05	0.00994	CbGpPWpGaD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	3.93e-05	0.00955	CbGpPWpGaD
Rosiglitazone—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	3.89e-05	0.00945	CbGpPWpGaD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	3.81e-05	0.00927	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	3.69e-05	0.00896	CbGpPWpGaD
Rosiglitazone—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	3.54e-05	0.00861	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—GPX4—Crohn's disease	3.47e-05	0.00843	CbGpPWpGaD
Rosiglitazone—PPARG—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	3.37e-05	0.00819	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	3.27e-05	0.00795	CbGpPWpGaD
Rosiglitazone—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	3.26e-05	0.00793	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	3.25e-05	0.0079	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PLA2G4F—Crohn's disease	3.22e-05	0.00782	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Bile acid and bile salt metabolism—ALB—Crohn's disease	3.03e-05	0.00736	CbGpPWpGaD
Rosiglitazone—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	3.03e-05	0.00736	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—F5—Crohn's disease	3.01e-05	0.00731	CbGpPWpGaD
Rosiglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	2.95e-05	0.00716	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	2.9e-05	0.00705	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	2.87e-05	0.00697	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	2.78e-05	0.00675	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	2.78e-05	0.00675	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	2.75e-05	0.00669	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—MTMR3—Crohn's disease	2.74e-05	0.00665	CbGpPWpGaD
Rosiglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	2.73e-05	0.00663	CbGpPWpGaD
Rosiglitazone—PPARG—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	2.72e-05	0.00661	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	2.7e-05	0.00656	CbGpPWpGaD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	2.65e-05	0.00645	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—MPO—Crohn's disease	2.64e-05	0.00643	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Crohn's disease	2.59e-05	0.00629	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	2.51e-05	0.0061	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—SOCS1—Crohn's disease	2.38e-05	0.00579	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.22e-05	0.00539	CbGpPWpGaD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	2.14e-05	0.00521	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—FADS1—Crohn's disease	2.13e-05	0.00518	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	2.11e-05	0.00513	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	2.1e-05	0.0051	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—SMAD3—Crohn's disease	2.06e-05	0.005	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—GPX4—Crohn's disease	2e-05	0.00485	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.96e-05	0.00476	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—GCKR—Crohn's disease	1.93e-05	0.00468	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.89e-05	0.00458	CbGpPWpGaD
Rosiglitazone—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	1.87e-05	0.00454	CbGpPWpGaD
Rosiglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.81e-05	0.00441	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	1.75e-05	0.00425	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.75e-05	0.00424	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.73e-05	0.0042	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	1.72e-05	0.00418	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	1.71e-05	0.00415	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—PTRF—Crohn's disease	1.68e-05	0.00407	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	1.6e-05	0.00388	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	1.59e-05	0.00386	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	1.59e-05	0.00386	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.58e-05	0.00384	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	1.57e-05	0.00382	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.55e-05	0.00377	CbGpPWpGaD
Rosiglitazone—PPARG—Signaling events mediated by HDAC Class I—STAT3—Crohn's disease	1.54e-05	0.00375	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.48e-05	0.00361	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.47e-05	0.00357	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	1.43e-05	0.00347	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.41e-05	0.00343	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.41e-05	0.00343	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—CRP—Crohn's disease	1.39e-05	0.00338	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.38e-05	0.00335	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.38e-05	0.00334	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	1.33e-05	0.00324	CbGpPWpGaD
Rosiglitazone—PPARG—Signaling events mediated by HDAC Class I—TNF—Crohn's disease	1.33e-05	0.00324	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.32e-05	0.00321	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	1.32e-05	0.0032	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	1.31e-05	0.00319	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	1.3e-05	0.00316	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—ICAM1—Crohn's disease	1.28e-05	0.00311	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	1.24e-05	0.00301	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.21e-05	0.00293	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	1.2e-05	0.00292	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	1.2e-05	0.00291	CbGpPWpGaD
Rosiglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.17e-05	0.00285	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.16e-05	0.00281	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.15e-05	0.0028	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.12e-05	0.00272	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	1.11e-05	0.0027	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	1.1e-05	0.00268	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.08e-05	0.00263	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	1.07e-05	0.00261	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	1.07e-05	0.00259	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—UBE2D1—Crohn's disease	1.05e-05	0.00255	CbGpPWpGaD
Rosiglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.05e-05	0.00254	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.03e-05	0.0025	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	1.02e-05	0.00247	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—ZFP36L1—Crohn's disease	1e-05	0.00244	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1e-05	0.00244	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.97e-06	0.00242	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.94e-06	0.00242	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	9.88e-06	0.0024	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PLA2G4F—Crohn's disease	9.87e-06	0.0024	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IFNG—Crohn's disease	9.72e-06	0.00236	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.63e-06	0.00234	CbGpPWpGaD
Rosiglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	9.53e-06	0.00232	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—STAT3—Crohn's disease	9.4e-06	0.00228	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	9.08e-06	0.00221	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.95e-06	0.00218	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.79e-06	0.00214	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	8.7e-06	0.00212	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IL1B—Crohn's disease	8.67e-06	0.00211	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—DNMT3A—Crohn's disease	8.53e-06	0.00207	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.53e-06	0.00207	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.48e-06	0.00206	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—MTMR3—Crohn's disease	8.4e-06	0.00204	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.16e-06	0.00198	CbGpPWpGaD
Rosiglitazone—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	8.14e-06	0.00198	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—TNF—Crohn's disease	8.13e-06	0.00198	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	8.1e-06	0.00197	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.06e-06	0.00196	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.06e-06	0.00196	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	8e-06	0.00195	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	7.79e-06	0.00189	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	7.77e-06	0.00189	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	7.74e-06	0.00188	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	7.74e-06	0.00188	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	7.73e-06	0.00188	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.61e-06	0.00185	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—SMAD3—Crohn's disease	7.51e-06	0.00183	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	7.41e-06	0.0018	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—SMAD3—Crohn's disease	7.07e-06	0.00172	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.98e-06	0.0017	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.94e-06	0.00169	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PLA2G4F—Crohn's disease	6.92e-06	0.00168	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	6.89e-06	0.00167	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—F5—Crohn's disease	6.88e-06	0.00167	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.65e-06	0.00162	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—MTMR3—Crohn's disease	6.61e-06	0.00161	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.61e-06	0.00161	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—IL6—Crohn's disease	6.56e-06	0.0016	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	6.54e-06	0.00159	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—FADS1—Crohn's disease	6.54e-06	0.00159	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TNF—Crohn's disease	6.29e-06	0.00153	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	6.28e-06	0.00153	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	6.24e-06	0.00152	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.23e-06	0.00151	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.22e-06	0.00151	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.19e-06	0.0015	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ALB—Crohn's disease	6.13e-06	0.00149	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GPX4—Crohn's disease	6.12e-06	0.00149	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.93e-06	0.00144	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.93e-06	0.00144	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GCKR—Crohn's disease	5.92e-06	0.00144	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—MTMR3—Crohn's disease	5.88e-06	0.00143	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	5.88e-06	0.00143	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	5.88e-06	0.00143	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—HSPA1B—Crohn's disease	5.77e-06	0.0014	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.68e-06	0.00138	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	5.61e-06	0.00136	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MTMR3—Crohn's disease	5.56e-06	0.00135	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.55e-06	0.00135	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.41e-06	0.00131	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PTGS2—Crohn's disease	5.37e-06	0.0013	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—FADS1—Crohn's disease	5.15e-06	0.00125	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IL6—Crohn's disease	5.08e-06	0.00123	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.06e-06	0.00123	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—UBE2D1—Crohn's disease	5.06e-06	0.00123	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.02e-06	0.00122	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	5e-06	0.00122	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GPX4—Crohn's disease	4.82e-06	0.00117	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GCKR—Crohn's disease	4.66e-06	0.00113	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—IL6—Crohn's disease	4.63e-06	0.00113	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.62e-06	0.00112	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TYK2—Crohn's disease	4.61e-06	0.00112	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—FADS1—Crohn's disease	4.58e-06	0.00111	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	4.47e-06	0.00109	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PLA2G4F—Crohn's disease	4.44e-06	0.00108	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—JAK2—Crohn's disease	4.4e-06	0.00107	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—FADS1—Crohn's disease	4.33e-06	0.00105	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.33e-06	0.00105	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GPX4—Crohn's disease	4.29e-06	0.00104	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—ITGA4—Crohn's disease	4.23e-06	0.00103	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.23e-06	0.00103	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GCKR—Crohn's disease	4.14e-06	0.00101	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL3—Crohn's disease	4.12e-06	0.001	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GPX4—Crohn's disease	4.06e-06	0.000986	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	4.04e-06	0.000981	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RASGRP1—Crohn's disease	3.99e-06	0.00097	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	3.99e-06	0.000969	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GCKR—Crohn's disease	3.92e-06	0.000952	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTMR3—Crohn's disease	3.8e-06	0.000923	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTMR3—Crohn's disease	3.78e-06	0.000918	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	3.77e-06	0.000916	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.7e-06	0.000899	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.67e-06	0.000892	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	3.64e-06	0.000884	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—SMAD3—Crohn's disease	3.62e-06	0.000879	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.39e-06	0.000824	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.33e-06	0.000809	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—STAT3—Crohn's disease	3.23e-06	0.000785	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.16e-06	0.000769	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTMR3—Crohn's disease	3.12e-06	0.000758	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	3.11e-06	0.000755	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTMR3—Crohn's disease	3.09e-06	0.000751	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.96e-06	0.00072	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—FADS1—Crohn's disease	2.96e-06	0.000719	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—FADS1—Crohn's disease	2.94e-06	0.000715	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.91e-06	0.000708	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2RA—Crohn's disease	2.89e-06	0.000702	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TNF—Crohn's disease	2.8e-06	0.000679	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX4—Crohn's disease	2.77e-06	0.000674	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX4—Crohn's disease	2.76e-06	0.00067	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GCKR—Crohn's disease	2.68e-06	0.000651	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GCKR—Crohn's disease	2.66e-06	0.000647	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTMR3—Crohn's disease	2.64e-06	0.000642	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—FADS1—Crohn's disease	2.64e-06	0.000642	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.59e-06	0.00063	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX4—Crohn's disease	2.47e-06	0.000601	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—FADS1—Crohn's disease	2.43e-06	0.000591	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—FADS1—Crohn's disease	2.41e-06	0.000585	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GCKR—Crohn's disease	2.39e-06	0.000581	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX4—Crohn's disease	2.28e-06	0.000553	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—IL6—Crohn's disease	2.26e-06	0.000548	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX4—Crohn's disease	2.26e-06	0.000548	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GCKR—Crohn's disease	2.2e-06	0.000534	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GCKR—Crohn's disease	2.18e-06	0.000529	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—FADS1—Crohn's disease	2.06e-06	0.0005	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—JAK2—Crohn's disease	1.94e-06	0.000472	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX4—Crohn's disease	1.93e-06	0.000468	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.91e-06	0.000465	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—Crohn's disease	1.88e-06	0.000458	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCKR—Crohn's disease	1.86e-06	0.000452	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.71e-06	0.000415	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.67e-06	0.000407	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.66e-06	0.000404	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—Crohn's disease	1.65e-06	0.0004	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.56e-06	0.000378	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.49e-06	0.000363	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—Crohn's disease	1.48e-06	0.00036	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.36e-06	0.000331	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.33e-06	0.000323	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—Crohn's disease	1.32e-06	0.000321	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—Crohn's disease	1.3e-06	0.000315	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—Crohn's disease	1.25e-06	0.000303	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.16e-06	0.000283	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—Crohn's disease	1.15e-06	0.00028	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—Crohn's disease	1.09e-06	0.000265	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—Crohn's disease	8.52e-07	0.000207	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—Crohn's disease	7.6e-07	0.000185	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—Crohn's disease	7.45e-07	0.000181	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—Crohn's disease	7.41e-07	0.00018	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—Crohn's disease	6.99e-07	0.00017	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—Crohn's disease	6.93e-07	0.000169	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—Crohn's disease	6.65e-07	0.000162	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—Crohn's disease	6.12e-07	0.000149	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—Crohn's disease	6.07e-07	0.000147	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—Crohn's disease	5.92e-07	0.000144	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—Crohn's disease	5.18e-07	0.000126	CbGpPWpGaD
